Published by Coherent Market Insights
Posted on September 20, 2021
4 min readLast updated: February 5, 2026
The Neuro-interventional Devices Market is set to reach $1,327.9M by 2027, driven by high ischemic stroke rates and an aging population.
Neurointervention is a medical specialty that uses minimally-invasive, catheter-based approaches for the treatment of specific diseases of the blood vessels of the head, neck and spine. Flow diverters, embolic coils, aneurysm clips, neurovascular stents, aspiration devices, and support devices are some of the most commonly adopted neurointerventional devices.
High incidence of ischemic strokes is expected to propel growth of the global neurointerventional devices market over the forecast period. For instance, according to the study, ‘Global, Regional, and National Burden of Stroke, 1990–2016: a Systematic Analysis for the Global Burden of Disease Study 2016, published in the journal The Lancet Neurology in March 2019, 80·1 million people suffered from stroke globally in 2016, of which 84·4% were ischemic. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.
Request for Sample Copy of report: https://www.coherentmarketinsights.com/insight/request-sample/3200
The global neuro-interventional devices market size is estimated to be valued at US$ 2358.1 million in 2020 and is expected to exhibit a CAGR of 4.0 % over the forecast period (2020-2027).
However, low number of interventional radiologists is expected to hamper growth of the global neurointerventional devices market.
Among product type, the embolic coils segment is expected to witness significant growth in the global neurointerventional devices market. The segment was valued at US$ 730.3 Mn in 2018 and is expected to reach US$ 1,044.4 Mn by 2027 at a CAGR of 4.1% during the forecast period.
Among end users, the hospitals segment is expected to hold dominant position in the global neurointerventional devices market over the forecast period. This is attributed to increasing funding in hospitals. For instance, according to Australian Institute of Health and Welfare’s Hospitals at a glance 2017–18 report updated in August 2019, funding for hospital services increased between 2016-2017 and 2017-2018 by 1.8% per year on average in public hospitals and by 2.9% per year on average in private hospitals in Australia. The segment held dominant position in the market in 2018, accounting for 90.1% share in terms of value, followed by clinics.
Get Flat USD 2000 OFF
Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/3200
Reasons to Purchase this Report:
Current and future of global Neuro-interventional Devices Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Key Takeaways:
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Informative Report on (COVID-19 Updates) Neuro-interventional Devices Market is Generating Revenue of US$ 1,327.9 Million by 2027 appeared first on Gatorledger.
The article discusses the growth and trends in the Neuro-interventional Devices Market, projected to reach $1,327.9M by 2027.
The high incidence of ischemic strokes and an increasing geriatric population are primary growth drivers.
The embolic coils segment is expected to witness significant growth in the market.
Explore more articles in the Research Reports category
